- Home
- CRDO vs HALO Comparison
CRDO vs HALO Comparison
Compare CRDO & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDO
- HALO
- Stock Information
- Founded
- CRDO 2008
- HALO 1998
- Country
- CRDO Cayman Islands
- HALO United States
- Employees
- CRDO N/A
- HALO N/A
- Industry
- CRDO Semiconductors
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRDO Technology
- HALO Health Care
- Exchange
- CRDO Nasdaq
- HALO Nasdaq
- Market Cap
- CRDO 7.3B
- HALO 7.4B
- IPO Year
- CRDO 2022
- HALO N/A
- Fundamental
- Price
- CRDO $60.45
- HALO $53.93
- Analyst Decision
- CRDO Strong Buy
- HALO Buy
- Analyst Count
- CRDO 10
- HALO 9
- Target Price
- CRDO $68.00
- HALO $63.56
- AVG Volume (30 Days)
- CRDO 3.7M
- HALO 3.3M
- Earning Date
- CRDO 06-02-2025
- HALO 05-06-2025
- Dividend Yield
- CRDO N/A
- HALO N/A
- EPS Growth
- CRDO N/A
- HALO 55.40
- EPS
- CRDO 0.03
- HALO 3.76
- Revenue
- CRDO $327,532,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- CRDO $125.51
- HALO $25.77
- Revenue Next Year
- CRDO $58.82
- HALO $18.01
- P/E Ratio
- CRDO $1,959.98
- HALO $14.34
- Revenue Growth
- CRDO 99.38
- HALO 25.64
- 52 Week Low
- CRDO $18.54
- HALO $42.01
- 52 Week High
- CRDO $86.69
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- CRDO 70.31
- HALO 43.12
- Support Level
- CRDO $57.21
- HALO $47.50
- Resistance Level
- CRDO $61.44
- HALO $69.94
- Average True Range (ATR)
- CRDO 2.84
- HALO 3.40
- MACD
- CRDO 1.18
- HALO -0.89
- Stochastic Oscillator
- CRDO 82.18
- HALO 27.94
About CRDO Credo Technology Group Holding Ltd
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.